Circulation. 2001;104:1863-1867
doi: 10.1161/hc4201.097189
doi: 10.1161/hc4201.097189
(Circulation. 2001;104:1863.)
© 2001 American Heart Association, Inc.
Current Perspective |
Improving Coronary Heart Disease Risk Assessment in Asymptomatic People
Role of Traditional Risk Factors and Noninvasive Cardiovascular Tests
From the Departments of Preventive Medicine and Medicine, Northwestern University Medical School, Chicago, Ill (P.G.); the Division of Cardiology, Center for Cardiovascular Science and Medicine, University of North Carolina at Chapel Hill (S.C.S.); and the Departments of Clinical Nutrition and Internal Medicine, University of Texas Southwestern Medical Center, Dallas (S.M.G.).
Correspondence to Philip Greenland, MD, Department of Preventive Medicine, Northwestern University Medical School, 680 N Lake Shore Dr, Suite 1102, Chicago, IL 60611. E-mail p-greenland@northwestern.edu
Key Words: coronary disease • prevention • prognosis • risk factors
 |
Introduction |
|---|
At least 25% of coronary patients have sudden death or nonfatal myocardial infarction without prior symptoms.1 Therefore, the search for coronary patients with subclinical disease who could potentially benefit from intensive primary prevention efforts is critically important. The American Heart Association’s (AHA) Prevention V Conference, "Beyond Secondary Prevention: Identifying the High Risk Patient for Primary Prevention," addressed ways to identify more patients who are asymptomatic and clinically free of coronary heart disease (CHD) but at sufficiently high risk for a future coronary event to justify more intensive risk reduction efforts.2 In this report, we amplify on key findings and recommendations of the AHA Prevention V conference, highlight new research since the conference, and propose an approach to the use of office-based testing and additional noninvasive procedures in selected patients to better define their coronary event risk. The recommendations are concordant with the recently released approach to risk assessment and management from the third report of the Adult Treatment Panel of the National Cholesterol Education Program (ATP-III).3
Enthusiasm for primary prevention and risk assessment in asymptomatic people has been spurred by recent advances in prevention research. Lipid-lowering trials demonstrated that primary prevention of coronary events is feasible, evidenced by the West of Scotland Coronary Primary Prevention Study (WOSCOPS) trial4 of hypercholesterolemic men and by the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) trial5 in average or typical risk men and women with only moderate lipid abnormalities. Aspirin6 or ACE inhibitors7 can also reduce risk in selected asymptomatic, high-risk people. Emerging coronary
This article has been cited by other articles:
 |
|
 |
|
  K. McGeechan, P. Macaskill, L. Irwig, G. Liew, and T. Y. Wong Assessing New Biomarkers and Predictive Models for Use in Clinical Practice: A Clinician's Guide Arch Intern Med, November 24, 2008; 168(21): 2304 - 2310. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Ankle Brachial Index Collaboration Ankle Brachial Index Combined With Framingham Risk Score to Predict Cardiovascular Events and Mortality: A Meta-analysis JAMA, July 9, 2008; 300(2): 197 - 208. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. C. Hoang, H. Ghandehari, V. A. Lopez, M. G. Barboza, and N. D. Wong Global Coronary Heart Disease Risk Assessment of Individuals With the Metabolic Syndrome in the U.S. Diabetes Care, July 1, 2008; 31(7): 1405 - 1409. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. R. Folsom, R. A. Kronmal, R. C. Detrano, D. H. O'Leary, D. E. Bild, D. A. Bluemke, M. J. Budoff, K. Liu, S. Shea, M. Szklo, et al. Coronary Artery Calcification Compared With Carotid Intima-Media Thickness in the Prediction of Cardiovascular Disease Incidence: The Multi-Ethnic Study of Atherosclerosis (MESA) Arch Intern Med, June 23, 2008; 168(12): 1333 - 1339. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Juonala, M. Kahonen, T. Laitinen, N. Hutri-Kahonen, E. Jokinen, L. Taittonen, M. Pietikainen, H. Helenius, J. S.A. Viikari, and O. T. Raitakari Effect of age and sex on carotid intima-media thickness, elasticity and brachial endothelial function in healthy adults: The Cardiovascular Risk in Young Finns Study Eur. Heart J., May 1, 2008; 29(9): 1198 - 1206. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Davidson, P. M. Meyer, S. Haffner, S. Feinstein, R. D'Agostino Sr, G. T. Kondos, A. Perez, Z. Chen, and T. Mazzone Increased High-Density Lipoprotein Cholesterol Predicts the Pioglitazone-Mediated Reduction of Carotid Intima-Media Thickness Progression in Patients With Type 2 Diabetes Mellitus Circulation, April 22, 2008; 117(16): 2123 - 2130. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Detrano, A. D. Guerci, J. J. Carr, D. E. Bild, G. Burke, A. R. Folsom, K. Liu, S. Shea, M. Szklo, D. A. Bluemke, et al. Coronary Calcium as a Predictor of Coronary Events in Four Racial or Ethnic Groups N. Engl. J. Med., March 27, 2008; 358(13): 1336 - 1345. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Rossi, A. Nuzzo, G. Origliani, and M. G. Modena Prognostic role of flow-mediated dilation and cardiac risk factors in post-menopausal women. J. Am. Coll. Cardiol., March 11, 2008; 51(10): 997 - 1002. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Blumenthal, C. N. Bairey Merz, V. Bittner, and T. J. Gluckman Task Force 10: Training in Preventive Cardiovascular Medicine J. Am. Coll. Cardiol., January 22, 2008; 51(3): 393 - 398. [Full Text] [PDF]
|
|
|
|
 |
|
 N. R. Cook Statistical Evaluation of Prognostic versus Diagnostic Models: Beyond the ROC Curve Clin. Chem., January 1, 2008; 54(1): 17 - 23. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. R. Preis and C. J. O'Donnell Coronary Heart Disease Risk Assessment by Traditional Risk Factors and Newer Subclinical Disease Imaging: Is a "One-Size-Fits-All" Approach the Best Option? Arch Intern Med, December 10, 2007; 167(22): 2399 - 2401. [Full Text] [PDF]
|
|
|
|
 |
|
 T. Schepis, O. Gaemperli, P. Koepfli, M. Namdar, I. Valenta, H. Scheffel, S. Leschka, L. Husmann, F. R. Eberli, T. F. Luscher, et al. Added Value of Coronary Artery Calcium Score as an Adjunct to Gated SPECT for the Evaluation of Coronary Artery Disease in an Intermediate-Risk Population J. Nucl. Med., September 1, 2007; 48(9): 1424 - 1430. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Kardys, R. Vliegenthart, M. Oudkerk, A. Hofman, and J. C. M. Witteman The Female Advantage in Cardiovascular Disease: Do Vascular Beds Contribute Equally? Am. J. Epidemiol., August 15, 2007; 166(4): 403 - 412. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Arena, J. Myers, M. A. Williams, M. Gulati, P. Kligfield, G. J. Balady, E. Collins, and G. Fletcher Assessment of Functional Capacity in Clinical and Research Settings: A Scientific Statement From the American Heart Association Committee on Exercise, Rehabilitation, and Prevention of the Council on Clinical Cardiology and the Council on Cardiovascular Nursing Circulation, July 17, 2007; 116(3): 329 - 343. [Full Text] [PDF]
|
|
|
|
|
|
W. Koenig Cardiovascular Biomarkers: Added Value With an Integrated Approach? Circulation, July 3, 2007; 116(1): 3 - 5. [Full Text] [PDF]
|
|
|
|
 |
|
 G. D. Harris A 52-Year-Old Woman With Hypertension and Diabetes Who Presents With Chest Pain Clin. Diabetes, July 1, 2007; 25(3): 115 - 118. [Full Text] [PDF]
|
|
|
|
|
|
X. Sui, M. J. LaMonte, and S. N. Blair Cardiorespiratory Fitness as a Predictor of Nonfatal Cardiovascular Events in Asymptomatic Women and Men Am. J. Epidemiol., June 15, 2007; 165(12): 1413 - 1423. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. M. Blanco-Colio, J. L. Martin-Ventura, B. Munoz-Garcia, J. Orbe, J. A. Paramo, J.-B. Michel, A. Ortiz, O. Meilhac, and J. Egido Identification of Soluble Tumor Necrosis Factor-Like Weak Inducer of Apoptosis (sTWEAK) as a Possible Biomarker of Subclinical Atherosclerosis Arterioscler. Thromb. Vasc. Biol., April 1, 2007; 27(4): 916 - 922. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Lauer Primary Prevention of Atherosclerotic Cardiovascular Disease: The High Public Burden of Low Individual Risk JAMA, March 28, 2007; 297(12): 1376 - 1378. [Full Text] [PDF]
|
|
|
|
|
|
J. G. Keevil, M. W. Cullen, R. Gangnon, P. E. McBride, and J. H. Stein Implications of Cardiac Risk and Low-Density Lipoprotein Cholesterol Distributions in the United States for the Diagnosis and Treatment of Dyslipidemia: Data From National Health and Nutrition Examination Survey 1999 to 2002 Circulation, March 20, 2007; 115(11): 1363 - 1370. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Thavendiranathan, A. Bagai, M. A. Brookhart, and N. K. Choudhry Primary Prevention of Cardiovascular Diseases With Statin Therapy: A Meta-analysis of Randomized Controlled Trials Arch Intern Med, November 27, 2006; 166(21): 2307 - 2313. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Budoff, S. Achenbach, R. S. Blumenthal, J. J. Carr, J. G. Goldin, P. Greenland, A. D. Guerci, J. A.C. Lima, D. J. Rader, G. D. Rubin, et al. Assessment of Coronary Artery Disease by Cardiac Computed Tomography: A Scientific Statement From the American Heart Association Committee on Cardiovascular Imaging and Intervention, Council on Cardiovascular Radiology and Intervention, and Committee on Cardiac Imaging, Council on Clinical Cardiology Circulation, October 17, 2006; 114(16): 1761 - 1791. [Full Text] [PDF]
|
|
|
|
|
|
M. J. Budoff Prevalence of Soft Plaque Detection With Computed Tomography J. Am. Coll. Cardiol., July 18, 2006; 48(2): 319 - 321. [Full Text] [PDF]
|
|
|
|
 |
|
 N. R. Cook, J. E. Buring, and P. M Ridker The Effect of Including C-Reactive Protein in Cardiovascular Risk Prediction Models for Women Ann Intern Med, July 4, 2006; 145(1): 21 - 29. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Raggi Noninvasive imaging of atherosclerosis among asymptomatic individuals. Arch Intern Med, May 22, 2006; 166(10): 1068 - 1071. [Full Text] [PDF]
|
|
|
|
|
|
R. S. Vasan Biomarkers of Cardiovascular Disease: Molecular Basis and Practical Considerations Circulation, May 16, 2006; 113(19): 2335 - 2362. [Full Text] [PDF]
|
|
|
|
|
|
R. D. Brook, R. L. Bard, S. Patel, M. Rubenfire, N. S. Clarke, E. A. Kazerooni, T. W. Wakefield, P. K. Henke, and K. A. Eagle A Negative Carotid Plaque Area Test Is Superior to Other Noninvasive Atherosclerosis Studies for Reducing the Likelihood of Having Underlying Significant Coronary Artery Disease Arterioscler. Thromb. Vasc. Biol., March 1, 2006; 26(3): 656 - 662. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Jerico, H. Knobel, N. Calvo, M. L. Sorli, A. Guelar, J. L. Gimeno-Bayon, P. Saballs, J. L. Lopez-Colomes, and J. Pedro-Botet Subclinical Carotid Atherosclerosis in HIV-Infected Patients: Role of Combination Antiretroviral Therapy Stroke, March 1, 2006; 37(3): 812 - 817. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Escolar, G. Weigold, A. Fuisz, and N. J. Weissman New imaging techniques for diagnosing coronary artery disease. Can. Med. Assoc. J., February 14, 2006; 174(4): 487 - 495. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N.F. Fanning, T.D. Walters, A.J. Fox, and S.P. Symons Association between Calcification of the Cervical Carotid Artery Bifurcation and White Matter Ischemia. AJNR Am. J. Neuroradiol., February 1, 2006; 27(2): 378 - 383. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A Cordero and E Alegria Sex differences and cardiovascular risk Heart, February 1, 2006; 92(2): 145 - 146. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Greenland and P. G. O'Malley When Is a New Prediction Marker Useful?: A Consideration of Lipoprotein-Associated Phospholipase A2 and C-Reactive Protein for Stroke Risk Arch Intern Med, November 28, 2005; 165(21): 2454 - 2456. [Full Text] [PDF]
|
|
|
|
|
|
P. W. F. Wilson, B.-H. Nam, M. Pencina, R. B. D'Agostino Sr, E. J. Benjamin, and C. J. O'Donnell C-Reactive Protein and Risk of Cardiovascular Disease in Men and Women From the Framingham Heart Study Arch Intern Med, November 28, 2005; 165(21): 2473 - 2478. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Mora, R. F. Redberg, A. R. Sharrett, and R. S. Blumenthal Enhanced Risk Assessment in Asymptomatic Individuals With Exercise Testing and Framingham Risk Scores Circulation, September 13, 2005; 112(11): 1566 - 1572. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Taylor, J. Bindeman, I. Feuerstein, F. Cao, M. Brazaitis, and P. G. O'Malley Coronary Calcium Independently Predicts Incident Premature Coronary Heart Disease Over Measured Cardiovascular Risk Factors: Mean Three-Year Outcomes in the Prospective Army Coronary Calcium (PACC) Project J. Am. Coll. Cardiol., September 6, 2005; 46(5): 807 - 814. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Lauer, E. S. Froelicher, M. Williams, and P. Kligfield Exercise Testing in Asymptomatic Adults: A Statement for Professionals From the American Heart Association Council on Clinical Cardiology, Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention Circulation, August 2, 2005; 112(5): 771 - 776. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Cushman, A. M. Arnold, B. M. Psaty, T. A. Manolio, L. H. Kuller, G. L. Burke, J. F. Polak, and R. P. Tracy C-Reactive Protein and the 10-Year Incidence of Coronary Heart Disease in Older Men and Women: The Cardiovascular Health Study Circulation, July 5, 2005; 112(1): 25 - 31. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Campbell, M. Woodward, J. P. Chalmers, S. A. Colman, A. J. Jenkins, B. E. Kemp, B. C. Neal, A. Patel, and S. W. MacMahon Prediction of Myocardial Infarction by N-Terminal-Pro-B-Type Natriuretic Peptide, C-Reactive Protein, and Renin in Subjects With Cerebrovascular Disease Circulation, July 5, 2005; 112(1): 110 - 116. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. K. Aktas and M. S. Lauer Global Risk Score and Exercise Testing--Reply JAMA, January 12, 2005; 293(2): 160 - 160. [Full Text] [PDF]
|
|
|
|
|
|
S. D. Persell Global Risk Score and Exercise Testing JAMA, January 12, 2005; 293(2): 159 - 159. [Full Text] [PDF]
|
|
|
|
|
|
O. Beloqui, J. A. Paramo, J. Orbe, A. Benito, I. Colina, A. Monasterio, and J. Diez Monocyte cyclooxygenase-2 overactivity: a new marker of subclinical atherosclerosis in asymptomatic subjects with cardiovascular risk factors? Eur. Heart J., January 2, 2005; 26(2): 153 - 158. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. C. Smith Jr, J. L. Anderson, R. O. Cannon III, Y. Y. Fadl, W. Koenig, P. Libby, S. E. Lipshultz, G. A. Mensah, P. M Ridker, and R. Rosenson CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: Report From the Clinical Practice Discussion Group Circulation, December 21, 2004; 110(25): e550 - e553. [Full Text] [PDF]
|
|
|
|
|
|
T. C. Register, K. P. Burdon, L. Lenchik, D. W. Bowden, G. A. Hawkins, B. J. Nicklas, K. Lohman, F.-C. Hsu, C. D. Langefeld, and J. J. Carr Variability of Serum Soluble Intercellular Adhesion Molecule-1 Measurements Attributable to a Common Polymorphism Clin. Chem., November 1, 2004; 50(11): 2185 - 2187. [Full Text] [PDF]
|
|
|
|
|
|
W. Koenig, N. Khuseyinova, H. Lowel, G. Trischler, and C. Meisinger Lipoprotein-Associated Phospholipase A2 Adds to Risk Prediction of Incident Coronary Events by C-Reactive Protein in Apparently Healthy Middle-Aged Men From the General Population: Results From the 14-Year Follow-Up of a Large Cohort From Southern Germany Circulation, October 5, 2004; 110(14): 1903 - 1908. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. K. Aktas, V. Ozduran, C. E. Pothier, R. Lang, and M. S. Lauer Global Risk Scores and Exercise Testing for Predicting All-Cause Mortality in a Preventive Medicine Program JAMA, September 22, 2004; 292(12): 1462 - 1468. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Herrington, W. V. Brown, L. Mosca, W. Davis, B. Eggleston, W. G. Hundley, and J. Raines Relationship Between Arterial Stiffness and Subclinical Aortic Atherosclerosis Circulation, July 27, 2004; 110(4): 432 - 437. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. M Ridker, P. W.F. Wilson, and S. M. Grundy Should C-Reactive Protein Be Added to Metabolic Syndrome and to Assessment of Global Cardiovascular Risk? Circulation, June 15, 2004; 109(23): 2818 - 2825. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Morshedi-Meibodi, J. C. Evans, D. Levy, M. G. Larson, and R. S. Vasan Clinical Correlates and Prognostic Significance of Exercise-Induced Ventricular Premature Beats in the Community: The Framingham Heart Study Circulation, May 25, 2004; 109(20): 2417 - 2422. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Koenig, H. Lowel, J. Baumert, and C. Meisinger C-Reactive Protein Modulates Risk Prediction Based on the Framingham Score: Implications for Future Risk Assessment: Results From a Large Cohort Study in Southern Germany Circulation, March 23, 2004; 109(11): 1349 - 1353. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. Ballantyne, R. C. Hoogeveen, H. Bang, J. Coresh, A. R. Folsom, G. Heiss, and A. R. Sharrett Lipoprotein-Associated Phospholipase A2, High-Sensitivity C-Reactive Protein, and Risk for Incident Coronary Heart Disease in Middle-Aged Men and Women in the Atherosclerosis Risk in Communities (ARIC) Study Circulation, February 24, 2004; 109(7): 837 - 842. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Greenland, L. LaBree, S. P. Azen, T. M. Doherty, and R. C. Detrano Coronary Artery Calcium Score Combined With Framingham Score for Risk Prediction in Asymptomatic Individuals JAMA, January 14, 2004; 291(2): 210 - 215. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Verma, M. R. Buchanan, and T. J. Anderson Endothelial Function Testing as a Biomarker of Vascular Disease Circulation, October 28, 2003; 108(17): 2054 - 2059. [Full Text] [PDF]
|
|
|
|
|
|
A. B. Newman, A. M. Arnold, B. L. Naydeck, L. P. Fried, G. L. Burke, P. Enright, J. Gottdiener, C. Hirsch, D. O'Leary, and R. Tracy "Successful Aging": Effect of Subclinical Cardiovascular Disease Arch Intern Med, October 27, 2003; 163(19): 2315 - 2322. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. B. Mark and M. S. Lauer Exercise Capacity: The Prognostic Variable That Doesn't Get Enough Respect Circulation, September 30, 2003; 108(13): 1534 - |